Procurement Summary
Country: Czech Republic
Summary: Supplies of Medicinal Products with the Active Substance Ofatumumab 2026
Deadline: 04 May 2026
Posting Date: 03 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138967869
Document Ref. No.: 233782-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: CZK 103000000
CPV Classification
33652000 - Antineoplastic and immunomodulating agents
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The subject of the public contract is the provision of continuous supplies of medicinal products with the active substance OFATUMUMAB for the needs of the contracting authority, as a provider of health services (not for the needs of resale/dispensing), including their direct shipment to pharmacies in individual spin-off plants of the contracting authority, on the basis of a framework agreement concluded with one selected supplier for a period of 24 months from the conclusion of the framework agreement. Supplies of medicinal products with the active substance OFATUMUMAB 2026 Doc Title: Supplies of medicinal products s active substance OFATUMUMAB 2026 Contract Type: supplies
Document Type: Contract Notice Reference Number: 5033/2026 Contract Type: supplies Estimated Value: 103000000 - CZK Authority Type: body-pl-cga Doc Title: Supplies of medicinal products with the active substance OFATUMUMAB 2026 Dispatch Date: 2026-04-02 Publish Date: 2026-04-03 Submission Date: 2026-05-04
Documents
Tender Notice